. 2014 Feb 26;5(1):17–29. doi: 10.1007/s13193-014-0291-x

Table 3.

Risk to fertility with different modalities of radiotherapy & chemotherapy

Risk	Treatment [18]
Low <20 %	1. Breast cancer or severe autoimmune disease chemotherapy in women less than 30 years: • Alkylating agent chemotherapy (Cyclophosphamide, Busulfan, Melphalan or Chlorambucil) 2. Breast cancer combination chemotherapy in women less than 40 years: • Alkylating agent chemotherapy (Cyclophosphamide, Busulfan or Melaphan) plus Doxorubicin 3. Cancer chemotherapy for: • Leukemia (ALL, AML) • Non Hodgkin Lymphoma

Risk

Treatment [18]

Low <20 %

1. Breast cancer or severe autoimmune disease chemotherapy in women less than 30 years:
• Alkylating agent chemotherapy (Cyclophosphamide, Busulfan, Melphalan or Chlorambucil)
2. Breast cancer combination chemotherapy in women less than 40 years:
• Alkylating agent chemotherapy (Cyclophosphamide, Busulfan or Melaphan) plus Doxorubicin
3. Cancer chemotherapy for:
• Leukemia (ALL, AML)
• Non Hodgkin Lymphoma